Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by RichyRich$on Feb 05, 2014 11:31pm
235 Views
Post# 22177736

Sernova a Biotech Buy Out Target ...

Sernova a Biotech Buy Out Target ...I have a feeling something big is stewing behind the scenes and ready to happen soon. Hiring a sought after CFO could be hint of a big move happening soon.  Possibly a Biotech buyout of Sernova.  It also makes sense that a CFO like this that raised over $1 Billion at her previous health care company would not take on a roll with Sernova if she doesn't see the potential.

"Ms. Steiner is an industry veteran with over 20 years of experience working with health care companies as an investment banker, financial and capital markets adviser, and management consultant. Prior to joining Sernova, Ms. Steiner was managing director of Nucleus GC, an advisory services boutique specializing in the health care and life sciences sector. In this capacity, she advised health care clients at all stages of development on financings, mergers and acquisitions, business development, and growth strategy.

Previously she held the positions of executive director, health care investment banking, for CIBC World Markets, and vice-president, health care investment banking, for Yorkton Securities, where she was instrumental in raising over $1-billion in financing for Canadian companies, as well as in mergers and acquisitions worth in excess of $2-billion. Earlier, Ms. Steiner was senior tax specialist at Deloitte."

https://www.stockwatch.com/News/Item.aspx?bid=Z-C:SVA-2142900&symbol=SVA&region=C


Bullboard Posts